These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 17561309)

  • 1. Proteasome inhibitor lactacystin disturbs the intracellular calcium homeostasis of dopamine neurons in ventral mesencephalic cultures.
    Li X; Yang D; Li L; Peng C; Chen S; Le W
    Neurochem Int; 2007 Jun; 50(7-8):959-65. PubMed ID: 17561309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple molecular pathways are involved in the neuroprotection of GDNF against proteasome inhibitor induced dopamine neuron degeneration in vivo.
    Du Y; Li X; Yang D; Zhang X; Chen S; Huang K; Le W
    Exp Biol Med (Maywood); 2008 Jul; 233(7):881-90. PubMed ID: 18445767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nurr1 deficiency predisposes to lactacystin-induced dopaminergic neuron injury in vitro and in vivo.
    Pan T; Zhu W; Zhao H; Deng H; Xie W; Jankovic J; Le W
    Brain Res; 2008 Jul; 1222():222-9. PubMed ID: 18579122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic iron chelation protects against proteasome inhibition-induced dopamine neuron degeneration.
    Zhu W; Li X; Xie W; Luo F; Kaur D; Andersen JK; Jankovic J; Le W
    Neurobiol Dis; 2010 Feb; 37(2):307-13. PubMed ID: 19818853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteasome inhibition modeling nigral neuron degeneration in Parkinson's disease.
    Xie W; Li X; Li C; Zhu W; Jankovic J; Le W
    J Neurochem; 2010 Oct; 115(1):188-99. PubMed ID: 20649845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pramipexole has astrocyte-mediated neuroprotective effects against lactacystin toxicity.
    Imamura K; Takeshima T; Nakaso K; Ito S; Nakashima K
    Neurosci Lett; 2008 Aug; 440(2):97-102. PubMed ID: 18555604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteasome inhibitor lactacystin ablates liver injury induced by intestinal ischaemia-reperfusion.
    Yao JH; Li YH; Wang ZZ; Zhang XS; Wang YZ; Yuan JC; Zhou Q; Liu KX; Tian XF
    Clin Exp Pharmacol Physiol; 2007 Nov; 34(11):1102-8. PubMed ID: 17880361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention and restoration of lactacystin-induced nigrostriatal dopamine neuron degeneration by novel brain-permeable iron chelators.
    Zhu W; Xie W; Pan T; Xu P; Fridkin M; Zheng H; Jankovic J; Youdim MB; Le W
    FASEB J; 2007 Dec; 21(14):3835-44. PubMed ID: 17690154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of somatodendritic dopamine release by corticotropin-releasing factor via the inhibition of voltage-operated Ca2+ channels.
    Kim Y; Park MK; Chung S
    Neurosci Lett; 2009 Nov; 465(1):31-5. PubMed ID: 19729048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotection of rapamycin in lactacystin-induced neurodegeneration via autophagy enhancement.
    Pan T; Kondo S; Zhu W; Xie W; Jankovic J; Le W
    Neurobiol Dis; 2008 Oct; 32(1):16-25. PubMed ID: 18640276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteasome inhibition induces selective motor neuron death in organotypic slice cultures.
    Tsuji S; Kikuchi S; Shinpo K; Tashiro J; Kishimoto R; Yabe I; Yamagishi S; Takeuchi M; Sasaki H
    J Neurosci Res; 2005 Nov; 82(4):443-51. PubMed ID: 16235246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteasomal inhibition and apoptosis regulatory changes in human isolated lymphocytes: the synergistic role of dopamine.
    Bazzini E; Samuele A; Granelli M; Levandis G; Armentero MT; Nappi G; Blandini F
    J Cell Biochem; 2008 Feb; 103(3):877-85. PubMed ID: 17647258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impairment of the ubiquitin-proteasome system causes dopaminergic cell death and inclusion body formation in ventral mesencephalic cultures.
    McNaught KS; Mytilineou C; Jnobaptiste R; Yabut J; Shashidharan P; Jennert P; Olanow CW
    J Neurochem; 2002 Apr; 81(2):301-6. PubMed ID: 12064477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A mechanistic study of proteasome inhibition-induced iron misregulation in dopamine neuron degeneration.
    Li XP; Xie WJ; Zhang Z; Kansara S; Jankovic J; Le WD
    Neurosignals; 2012; 20(4):223-36. PubMed ID: 22269801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolonged membrane depolarization enhances midbrain dopamine neuron differentiation via epigenetic histone modifications.
    He XB; Yi SH; Rhee YH; Kim H; Han YM; Lee SH; Lee H; Park CH; Lee YS; Richardson E; Kim BW; Lee SH
    Stem Cells; 2011 Nov; 29(11):1861-73. PubMed ID: 21922608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroprotection by iron chelator against proteasome inhibitor-induced nigral degeneration.
    Zhang X; Xie W; Qu S; Pan T; Wang X; Le W
    Biochem Biophys Res Commun; 2005 Jul; 333(2):544-9. PubMed ID: 15950935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms involved in the formation of dopamine-induced intracellular bodies within striatal neurons.
    Lazzeri G; Lenzi P; Busceti CL; Ferrucci M; Falleni A; Bruno V; Paparelli A; Fornai F
    J Neurochem; 2007 Jun; 101(5):1414-27. PubMed ID: 17286589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pitx3-transfected astrocytes secrete brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor and protect dopamine neurons in mesencephalon cultures.
    Yang D; Peng C; Li X; Fan X; Li L; Ming M; Chen S; Le W
    J Neurosci Res; 2008 Nov; 86(15):3393-400. PubMed ID: 18646205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of neuroprotective and neurorestorative capabilities of rasagiline and selegiline against lactacystin-induced nigrostriatal dopaminergic degeneration.
    Zhu W; Xie W; Pan T; Jankovic J; Li J; Youdim MB; Le W
    J Neurochem; 2008 Jun; 105(5):1970-8. PubMed ID: 18399960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine release in organotypic cultures of foetal mouse mesencephalon: effects of depolarizing agents, pargyline, nomifensine, tetrodotoxin and calcium.
    Larsen TR; Rossen S; Gramsbergen JB
    Eur J Neurosci; 2008 Aug; 28(3):569-76. PubMed ID: 18702728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.